Asherman Syndrome Clinical Trial
Official title:
Endometrial Reconstruction by Human Regenerative Factors Derived From Platelet-Rich Plasma in Mice Models
Infertility, which affected 48.5 million couples worldwide in 2010 alone, has many causes; some causes result from issues related to the endometrium. Unfortunately, no cure exists for medical conditions resulting in the destruction of the endometrium, or for non-functional uterus. Thus, safe and effective therapies are needed to treat these diseases and to establish fertility in affected women. These novel techniques refer to the use and application of regenerative/paracrine factors to regenerate the endometrium in patients with Asherman's Syndrome (AS) and Endometrial Atrophy (EA).These new therapies based on the injection of the identified regenerative/paracrine factors and the platelet-rich plasma (PRP) from whole blood in an immunodeficient mouse model with AS/EA, evaluating their contribution and/or effect in the endometrial repair by functional proofs.
The objective is to know the effect of these regenerative factors obtained from Platelet-Rich Plasma in an immunodeficient murine model with AS/EA Blood from patients with Asherman's Syndrome (AS) and Endometrial Atrophy (EA) will be collected, maintained under anticoagulant solution and after several centrifugations PRP will be obtained. Demonstration of a functional endometrium will be proved determining pregnancy and implantation rates as well as the number of live pups/pregnant female in our mice model. Also, the uterus histology will be analysed in treated and untreated mice ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01377779 -
Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions
|
N/A | |
| Not yet recruiting |
NCT05521932 -
Establishment and Application of Endometrial 3D-organoid in Endometrial Injury Repair
|
||
| Completed |
NCT04424160 -
Effects of Platelet Rich Plasma on Endometrium
|
N/A | |
| Active, not recruiting |
NCT04963179 -
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
|
N/A | |
| Completed |
NCT05414760 -
Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier
|
N/A | |
| Recruiting |
NCT05343572 -
Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
|
Early Phase 1 | |
| Completed |
NCT02867202 -
Adjuvant Therapy for Intrauterine Adhesions Between Two Groups
|
N/A | |
| Recruiting |
NCT03665649 -
Pre-clinical Endometrial Tissular Renovation Study
|
N/A | |
| Completed |
NCT05901948 -
Pre-Surgical Grading System of Asherman Syndrome
|
||
| Completed |
NCT02746679 -
Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion.
|
N/A | |
| Completed |
NCT02680366 -
Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells
|
N/A | |
| Not yet recruiting |
NCT04671914 -
Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.
|
Phase 4 | |
| Recruiting |
NCT01637974 -
Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery
|
N/A | |
| Completed |
NCT03166189 -
Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures
|
Phase 2 | |
| Enrolling by invitation |
NCT03620929 -
Estrogen in the Prevention of Adhesion Reformation
|
Phase 4 | |
| Recruiting |
NCT05095597 -
Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)
|
Phase 2 | |
| Completed |
NCT02726971 -
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
|
Phase 1/Phase 2 |